Eosinophilic esophagitis epidemiology and demographics

Revision as of 19:27, 19 December 2017 by Ahmed Younes (talk | contribs)
Jump to navigation Jump to search

Eosinophilic Esophagitis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Eosinophilic Esophagitis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Future or Investigational Therapies

Case Studies

Case #1

Eosinophilic esophagitis epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Eosinophilic esophagitis epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Eosinophilic esophagitis epidemiology and demographics

CDC on Eosinophilic esophagitis epidemiology and demographics

Eosinophilic esophagitis epidemiology and demographics in the news

Blogs on Eosinophilic esophagitis epidemiology and demographics

Directions to Hospitals Treating Eosinophilic esophagitis

Risk calculators and risk factors for Eosinophilic esophagitis epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Ajay Gade MD[2]]

Overview

The incidence Eosinophilic esophagitis (EoE) is approximately 10 per 100,000 individuals worldwide. The prevalence of EoE is approximately 50-100 per 100,000 individuals worldwide. Patients of all age groups may develop EoE. It usually affects individuals of the white race. Males are more commonly affected by EoE than females. EoE is a rare disease that tends to affect people with a history of European ancestry.

Epidemiology and Demographics

The Epidemiology and Demographics of the EoE are as follows:[1][2][3][4][5][6]

Incidence

  • The incidence EoE is approximately 10 per 100,000 individuals worldwide.

Prevalence

  • The prevalence of EoE is approximately 50-100 per 100,000 individuals worldwide.

Age

  • Patients of all age groups may develop EoE.

Race

  • EoE usually affects individuals of the white race.

Gender

  • Males are more commonly affected by EoE than females.

Region

  • EoE is a rare disease that tends to affect people with a history of European ancestry.

References

  1. Dellon ES (2014). "Epidemiology of eosinophilic esophagitis". Gastroenterol. Clin. North Am. 43 (2): 201–18. doi:10.1016/j.gtc.2014.02.002. PMC 4019938. PMID 24813510.
  2. Soon IS, Butzner JD, Kaplan GG, deBruyn JC (2013). "Incidence and prevalence of eosinophilic esophagitis in children". J. Pediatr. Gastroenterol. Nutr. 57 (1): 72–80. doi:10.1097/MPG.0b013e318291fee2. PMID 23539047.
  3. Sperry SL, Crockett SD, Miller CB, Shaheen NJ, Dellon ES (2011). "Esophageal foreign-body impactions: epidemiology, time trends, and the impact of the increasing prevalence of eosinophilic esophagitis". Gastrointest. Endosc. 74 (5): 985–91. doi:10.1016/j.gie.2011.06.029. PMC 3951006. PMID 21889135.
  4. Cianferoni A, Spergel JM (2015). "Eosinophilic Esophagitis and Gastroenteritis". Curr Allergy Asthma Rep. 15 (9): 58. doi:10.1007/s11882-015-0558-5. PMID 26233430.
  5. Furuta GT, Katzka DA (2015). "Eosinophilic Esophagitis". N. Engl. J. Med. 373 (17): 1640–8. doi:10.1056/NEJMra1502863. PMC 4905697. PMID 26488694.
  6. Kocsis D, Tulassay Z, Juhász M (2015). "[Dietary and pharmacological aspects of eosinophilic esophagitis]". Orv Hetil (in Hungarian). 156 (23): 927–32. doi:10.1556/650.2015.30164. PMID 26027600.


Template:Gastroenterology

Template:WH Template:WikiDoc Sources